Trio of prescription cost bills pass off Washington Senate floor
OLYMPIA, Wash. (AP) — The Washington Senate has passed three bills that aim to reign in the costs of prescription drugs.
One measure would cap the monthly out-of-pocket cost of insulin to $100 until Jan. 1, 2023 and requires the Health Care Authority to monitor the price of insulin.
Another seeks a longer-term cost containment for insulin by creating a centralized purchasing process for insulin based on the approach used by the state to purchase childhood vaccines.
The third measure establishes a prescription drug affordability board that would review prices and price increases to determine whether maximum price caps are needed.
The bills now head to the House for consideration.
COPYRIGHT 2020THE ASSOCIATED PRESS. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.